Product Information
DICLOFENAC EPOLAMINE 1.3% PTCH is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.8100 per EA under NDC 00093372755. Its NADAC has been published 323 times since Jun 17, 2020.
FDA first approved this application on Jan 31, 2007.
Strength
.013 g/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093372755
Classification
Generic
Dosage Form
SYSTEM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
DICLOFENAC EPOLAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021234FDA Approved
1/31/2007
On Market Since
5/1/2020
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has been published 323 times since Jun 17, 2020, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8100 per EA |
|---|---|
| All-time high | $7.1487 (Mar 10, 2021) |
| All-time low | $4.3538 (Feb 19, 2025) |
| 52-week high | $5.0729 |
| 52-week low | $4.4049 |
| Median price | $5.6309 |
| Average price | $5.5362 |
| Largest weekly change | +21.0% (Aug 21, 2024) |
| Weeks tracked | 323 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DICLOFENAC EPOLAMINE 1.3% PTCH?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC EPOLAMINE 1.3% PTCH, manufactured by Teva Pharmaceuticals USA Inc., is $4.8100 per EA (NDC 00093372755), effective Aug 19, 2026.
How has the price of DICLOFENAC EPOLAMINE 1.3% PTCH changed over time?
Over the history we have for it, the NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has declined 23.5%. It has been tracked across 323 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for DICLOFENAC EPOLAMINE 1.3% PTCH?
Since Jun 17, 2020, the NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has ranged from a low of $4.3538 (Feb 19, 2025) to a high of $7.1487 (Mar 10, 2021), with a median of $5.6309 per EA.
Are there cheaper alternatives to DICLOFENAC EPOLAMINE 1.3% PTCH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DICLOFENAC EPOLAMINE 1.3% PTCH in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC EPOLAMINE 1.3% PTCH?
DICLOFENAC EPOLAMINE 1.3% PTCH (NDC 00093372755) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.